Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2007-11-20
pubmed:abstractText
Adequate antiretroviral exposure during pregnancy is critical to prevent the vertical transmission of HIV and for maternal health. Pregnancy can alter drug kinetics. We assessed the pharmacokinetics of atazanavir/ritonavir (300/100 mg a day) during pregnancy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1473-5571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
30
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2409-15
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:18025877-Adult, pubmed-meshheading:18025877-Antiretroviral Therapy, Highly Active, pubmed-meshheading:18025877-Chromatography, High Pressure Liquid, pubmed-meshheading:18025877-Drug Administration Schedule, pubmed-meshheading:18025877-Drug Monitoring, pubmed-meshheading:18025877-Female, pubmed-meshheading:18025877-Fetal Blood, pubmed-meshheading:18025877-HIV Infections, pubmed-meshheading:18025877-HIV Protease Inhibitors, pubmed-meshheading:18025877-Humans, pubmed-meshheading:18025877-Infant, Newborn, pubmed-meshheading:18025877-Infectious Disease Transmission, Vertical, pubmed-meshheading:18025877-Male, pubmed-meshheading:18025877-Maternal-Fetal Exchange, pubmed-meshheading:18025877-Oligopeptides, pubmed-meshheading:18025877-Pregnancy, pubmed-meshheading:18025877-Pregnancy Complications, Infectious, pubmed-meshheading:18025877-Pregnancy Outcome, pubmed-meshheading:18025877-Pyridines, pubmed-meshheading:18025877-Ritonavir
pubmed:year
2007
pubmed:articleTitle
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.
pubmed:affiliation
Division of Infectious Diseases, Ospedali Riuniti, Bergamo, Italy.
pubmed:publicationType
Journal Article, Clinical Trial